» Articles » PMID: 27867193

From Profiles to Function in Epigenomics

Overview
Journal Nat Rev Genet
Specialty Genetics
Date 2016 Nov 22
PMID 27867193
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

Myriads of epigenomic features have been comprehensively profiled in health and disease across cell types, tissues and individuals. Although current epigenomic approaches can infer function for chromatin marks through correlation, it remains challenging to establish which marks actually have causative roles in gene regulation and other processes. After revisiting how classical approaches have addressed this question in the past, we discuss the current state of epigenomic profiling and how functional information can be indirectly inferred. We also present new approaches that promise definitive functional answers, which are collectively referred to as 'epigenome editing'. In particular, we explore CRISPR-based technologies for single-locus and multi-locus manipulation. Finally, we discuss which level of function can be achieved with each approach and introduce emerging strategies for high-throughput progression from profiles to function.

Citing Articles

Multi-omics approaches for understanding gene-environment interactions in noncommunicable diseases: techniques, translation, and equity issues.

Alemu R, Sharew N, Arsano Y, Ahmed M, Tekola-Ayele F, Mersha T Hum Genomics. 2025; 19(1):8.

PMID: 39891174 PMC: 11786457. DOI: 10.1186/s40246-025-00718-9.


Epigenetic Mechanisms in Aging: Extrinsic Factors and Gut Microbiome.

Borrego-Ruiz A, Borrego J Genes (Basel). 2025; 15(12.

PMID: 39766866 PMC: 11675900. DOI: 10.3390/genes15121599.


Epigenetics-targeted drugs: current paradigms and future challenges.

Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S Signal Transduct Target Ther. 2024; 9(1):332.

PMID: 39592582 PMC: 11627502. DOI: 10.1038/s41392-024-02039-0.


Using Callus as an Ex Vivo System for Chromatin Analysis.

Lavie O, Williams L Methods Mol Biol. 2024; 2873:333-347.

PMID: 39576610 DOI: 10.1007/978-1-0716-4228-3_18.


Modeling of skeletal development and diseases using human pluripotent stem cells.

Hojo H, Tani S, Ohba S J Bone Miner Res. 2024; 40(1):5-19.

PMID: 39498496 PMC: 11700608. DOI: 10.1093/jbmr/zjae178.


References
1.
Lane A, Strzelecka M, Ettinger A, Grenfell A, Wittmann T, Heald R . Enzymatically Generated CRISPR Libraries for Genome Labeling and Screening. Dev Cell. 2015; 34(3):373-8. PMC: 4536113. DOI: 10.1016/j.devcel.2015.06.003. View

2.
Bernstein D, Le Lay J, Ruano E, Kaestner K . TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts. J Clin Invest. 2015; 125(5):1998-2006. PMC: 4463192. DOI: 10.1172/JCI77321. View

3.
Schwartzman O, Tanay A . Single-cell epigenomics: techniques and emerging applications. Nat Rev Genet. 2015; 16(12):716-26. DOI: 10.1038/nrg3980. View

4.
Claussnitzer M, Dankel S, Kim K, Quon G, Meuleman W, Haugen C . FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. N Engl J Med. 2015; 373(10):895-907. PMC: 4959911. DOI: 10.1056/NEJMoa1502214. View

5.
Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A . Integrative analysis of 111 reference human epigenomes. Nature. 2015; 518(7539):317-30. PMC: 4530010. DOI: 10.1038/nature14248. View